Lv1
90 积分 2024-08-21 加入
Ofirnoflast: a first-in-class NEK7-targeted inhibitor of the NLRP3 inflammasome
1个月前
已完结
Tu1470 HZ-W084, A NOVEL VAV1 DEGRADER, ALLEVIATES DISEASE PROGRESSION IN PRE-CLINICAL MURINE COLITIS MODEL
2个月前
已完结
Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis
2个月前
已完结
Advances in host-directed therapy for tuberculosis and HIV coinfection: enhancing immune responses
10个月前
已完结
Host-directed therapies for bacterial and viral infections
10个月前
已完结
Advancing host-directed therapy for tuberculosis
10个月前
已完结
Efficient evolution of human antibodies from general protein language models
1年前
已完结
‘A landmark moment’: scientists use AI to design antibodies from scratch
1年前
已关闭
Polymeric PD-L1 blockade nanoparticles for cancer photothermal-immunotherapy
1年前
已完结
皖公网安备34019202002308
